Evidence map›Paper›PMID 33475463›Full record

ArticleCell cycle (Georgetown, Tex.)2021

Sufentanil preconditioning protects against myocardial ischemia/reperfusion injury via miR-125a/DRAM2 axis.

Qiaoling Wu, You Shang, Yanli Bai, Yuanyuan Wu, Hao Wang, Tu Shen

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Sufentanil promotes autophagy and improves ischemiaZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Qiaoling WuDepartment of Anesthesiology, The First Hospital Affiliated to Jinzhou Medical University , Jinzhou, P.R. China.
You ShangDepartment of Anesthesiology, The First Hospital Affiliated to Jinzhou Medical University , Jinzhou, P.R. China.
Yanli BaiDepartment of Anesthesiology, The First Hospital Affiliated to Jinzhou Medical University , Jinzhou, P.R. China.
Yuanyuan WuDepartment of Anesthesiology, The First Hospital Affiliated to Jinzhou Medical University , Jinzhou, P.R. China.
Hao WangDepartment of Anesthesiology, The First Hospital Affiliated to Jinzhou Medical University , Jinzhou, P.R. China.
Tu ShenDepartment of Anesthesiology, The First Hospital Affiliated to Jinzhou Medical University , Jinzhou, P.R. China.
Jinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This project aimed to investigate the protective mechanism of sufentanil pretreatment on myocardial ischemia-reperfusion injury (IRI). An

Indexed as

AnimalsCardiotonic AgentsCell Line, TransformedIschemic Preconditioning, MyocardialMaleMembrane ProteinsMicroRNAsMyocardial Reperfusion InjuryMyocytes, CardiacRatsRats, Sprague-DawleySufentanilCardiotonic AgentsDRAM2 protein, humanMembrane ProteinsMicroRNAsMirn125 microRNA, mouseSufentanilIschemia-reperfusion injurymiR-125amitochondrial autophagy

Identifiers

PMID33475463
PMCPMC7894415
OpenAlexW3125286021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.